We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+26.41%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$8.88B
AUM Growth
+$2.09B
Cap. Flow
+$564M
Cap. Flow %
6.36%
Top 10 Hldgs %
40.05%
Holding
908
New
100
Increased
273
Reduced
455
Closed
75

Sector Composition

Rank Sector Weight
1 Energy 48.15%
2 Financials 11.06%
3 Technology 6.82%
4 Healthcare 5.49%
5 Industrials 4.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WRK
401
DELISTED
WestRock Company
WRK
$869K 0.01%
19,954
-564,973
-97% -$23.3M
PGRE
402
DELISTED
Paramount Group
PGRE
$868K 0.01%
+96,008
New +$773K
PRTA icon
403
Prothena Corp
PRTA
$455M
$866K 0.01%
+72,138
New +$853K
AAT
404
American Assets Trust
AAT
$1.49B
$859K 0.01%
29,738
-1,704
-5% -$45.3K
CTAS icon
405
Cintas
CTAS
$84.4B
$857K 0.01%
9,696
-784
-7% -$68.1K
DEI icon
406
Douglas Emmett
DEI
$2.03B
$857K 0.01%
29,369
-2,284
-7% -$64.9K
MTEM
407
DELISTED
Molecular Templates, Inc.
MTEM
$847K 0.01%
6,015
+1,771
+42% +$262K
CRNX icon
408
Crinetics Pharmaceuticals
CRNX
$8.87B
$839K 0.01%
59,437
+17,503
+42% +$244K
EPAM icon
409
EPAM Systems
EPAM
$4.92B
$826K 0.01%
2,305
-192
-8% -$64.1K
NATI
410
DELISTED
National Instruments Corp
NATI
$824K 0.01%
18,763
-1,076
-5% -$40.2K
XBIT icon
411
XBiotech
XBIT
$68.9M
$820K 0.01%
52,398
+15,435
+42% +$284K
CVM icon
412
CEL-SCI Corp
CVM
$20.6M
$814K 0.01%
2,327
+685
+42% +$270K
AFMD
413
DELISTED
Affimed
AFMD
$802K 0.01%
+13,782
New +$649K
MIRM icon
414
Mirum Pharmaceuticals
MIRM
$6.96B
$802K 0.01%
+45,910
New +$903K
FMC icon
415
FMC
FMC
$1.39B
$800K 0.01%
6,962
-585
-8% -$65.1K
STWD icon
416
Starwood Property Trust
STWD
$6.15B
$792K 0.01%
+41,048
New +$698K
VRTX icon
417
Vertex Pharmaceuticals
VRTX
$122B
$772K 0.01%
3,266
-272
-8% -$62.4K
LNT icon
418
Alliant Energy
LNT
$19.1B
$766K 0.01%
14,858
-664
-4% -$35.7K
NKE icon
419
Nike
NKE
$62.5B
$761K 0.01%
5,377
-308
-5% -$40.8K
FNB icon
420
FNB Corp
FNB
$6.71B
$754K 0.01%
+79,372
New +$672K
GMDA
421
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$750K 0.01%
+89,421
New +$605K
WSM icon
422
Williams-Sonoma
WSM
$27.6B
$748K 0.01%
14,694
-1,310
-8% -$67.1K
VKTX icon
423
Viking Therapeutics
VKTX
$4.05B
$740K 0.01%
131,509
+38,719
+42% +$235K
CTSH icon
424
Cognizant
CTSH
$22.3B
$739K 0.01%
9,024
-700
-7% -$53.3K
PBYI icon
425
Puma Biotechnology
PBYI
$407M
$736K 0.01%
71,715
+21,118
+42% +$214K

Similar funds

ALPS Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, ALPS Advisors held 908 positions worth $8.88B, up 31% from $6.79B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

ALPS Advisors deployed $564M of net new capital in Q4 2020, opening 100 new positions and adding to 273 existing holdings. Its largest new stake was Genuine Parts: 212,300 shares worth $21.3M.

By sector, the portfolio is most concentrated in Energy at 48% of assets, up from 46% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was WestRock Company, an estimated $23.3M trimmed.

  • ALPS Advisors's largest Q4 2020 buy was Genuine Parts: 212,300 shares worth $21.3M.
  • ALPS Advisors added most to Energy Transfer Partners in Q4 2020, an estimated $76.1M increase.
  • ALPS Advisors's biggest Q4 2020 reduction was WestRock Company, cutting an estimated $23.3M.
  • ALPS Advisors fully exited Duke Energy in Q4 2020, selling an estimated $20.8M.
  • ALPS Advisors's ten largest holdings make up 40% of its $8.88B portfolio in Q4 2020.
  • ALPS Advisors opened 100 new positions and closed 75 in Q4 2020.
  • ALPS Advisors's portfolio value rose 31% quarter-over-quarter to $8.88B.

Based on ALPS Advisors's 13F filing for Q4 2020, filed 3 Feb 2021.